Brief: Interpace Biosciences Q3 Revenue USD 8.756 Million
Nov 12 (Reuters) - Interpace Biosciences Q3 net income USD 911 thousand. Q3 operating expenses USD 4.294 million Q3 gross profit USD 5.439 million Q3 operating income USD 1.145 million
Nov 12 (Reuters) - Interpace Biosciences Q3 net income USD 911 thousand. Q3 operating expenses USD 4.294 million Q3 gross profit USD 5.439 million Q3 operating income USD 1.145 million